XML 15 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 28, 2025
Dec. 29, 2024
Current assets:    
Cash and cash equivalents $ 931,386 $ 1,163,396
Accounts receivable, net 680,259 632,400
Inventories, net 379,917 367,587
Other current assets 152,226 186,225
Total current assets 2,143,788 2,349,608
Property, plant and equipment, net:    
Property, plant and equipment, net 497,088 482,217
Operating Lease, Right-of-Use Asset 171,078 167,716
Intangible assets, net 2,425,926 2,640,921
Goodwill 6,600,631 6,463,619
Other assets, net 300,441 288,397
Total assets 12,138,952 12,392,478
Current liabilities:    
Current portion of long-term debt 583,844 242
Accounts payable 175,800 167,463
Accrued expenses and other current liabilities 463,099 485,395
Total current liabilities 1,222,743 653,100
Long-term debt 2,630,693 3,150,476
Deferred taxes and other long-term liabilities 755,155 770,523
Operating Lease, Liability, Noncurrent 154,465 151,505
Total liabilities 4,763,056 4,725,604
Commitments and contingencies (see Note 13)
Stockholders' equity:    
Preferred stock—$1 par value per share, authorized 1,000,000 shares; none issued or outstanding 0 0
Common stock—$1 par value per share, authorized 300,000,000 shares; issued and outstanding 114,030,000 shares and 120,646,000 shares at September 28, 2025 and December 29, 2024, respectively 114,030 120,646
Capital in excess of par value 1,477,890 2,097,110
Retained earnings 5,963,781 5,845,223
Accumulated other comprehensive loss (179,805) (396,105)
Total stockholders’ equity 7,375,896 7,666,874
Total liabilities and stockholders’ equity $ 12,138,952 $ 12,392,478